UK physicians' attitudes towards direct-to-consumer advertising of prescription drugs: An extension and review

Reast, Jon D., Palihawadana, Dayananda and Spickett-Jones, Graham (2004) UK physicians' attitudes towards direct-to-consumer advertising of prescription drugs: An extension and review. International Journal of Advertising, 23 (2). pp. 229-252. ISSN 0265-0487

Full text not available from this repository.

Abstract

Since 1990 in New Zealand, and 1997 in the USA, legislation has controversially allowed brand owners to advertise prescription drugs direct to consumers (DTC), with advertising spends of approaching NZ$19 million in 2000, and US$2.7 billion in 2001 respectively. While DTC has faced a mixed response in the USA and New Zealand, there is significant pressure for similar DTC advertising within the EU. This study, a part replication of USA research by Petroshius et al. (1995), and an extension of Reast and Carson (2000), addresses the attitudes among 168 UK general practitioners and hospital doctors towards the concept and likely impact of DTC, and to generic .see your doctor. campaigns recently introduced in the UK and Europe. The study confirms that UK physicians, in common with New Zealand, and increasingly with US colleagues, are highly opposed to the concept and likely overall impact of DTC advertising, and also towards the impact of recently introduced .see your doctor. campaigns.

Item Type:	Article
Faculty \ School:	Faculty of Social Sciences > Norwich Business School
UEA Research Groups:	Faculty of Social Sciences > Research Groups > Marketing, Entrepreneurship and Business Strategy (former - to 2019)
Depositing User:	Anna Flack
Date Deposited:	21 Aug 2012 08:37
Last Modified:	06 Sep 2023 11:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/39366
DOI:	10.1080/02650487.2004.11072881

Actions (login required)

View Item